
Tortugas Neuroscience is a neurology-focused biotech company dedicated to developing effective medicines that address diseases of the brain. With a strategic focus on derisked mechanisms and rapid development pathways, Tortugas Neuroscience is committed to creating therapies with meaningful impact for patients worldwide.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 04/24/26 | $106,000,000 | Seed and Series A |
AN Ventures![]() Cure Ventures ![]() The Column Group ![]() | undisclosed |